Silexion Therapeutics Ltd.SLXNNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank84
3Y CAGR+470.6%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
+470.6%/yr
Quarterly compound
Percentile
P84
Within normal range
vs 3Y Ago
185.8x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 100.35% |
| Q2 2025 | -30.22% |
| Q1 2025 | 190.19% |
| Q4 2024 | -7.26% |
| Q3 2024 | 22.26% |
| Q2 2024 | -29.57% |
| Q1 2024 | -31.79% |
| Q4 2023 | -7.32% |
| Q3 2023 | -79.36% |
| Q2 2023 | 1.93% |
| Q1 2023 | 188.87% |
| Q4 2022 | -91.96% |
| Q3 2022 | 0.54% |
| Q2 2022 | -0.07% |
| Q1 2022 | 0.06% |
| Q4 2021 | -0.13% |
| Q3 2021 | -0.20% |
| Q2 2021 | -0.14% |
| Q1 2021 | 89514.27% |
| Q4 2020 | 0.00% |